54 filings
Page 2 of 3
6-K
tc4r4d
26 May 22
Current report (foreign)
6:15am
6-K
0xrd3o
10 May 22
Achilles Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
4:24pm
6-K
zqpnvx b1x54
4 May 22
Achilles Therapeutics Appoints Bernhard Ehmer to Board of Directors
4:49pm
S-8
z24a7jglr1t41
2 Mar 22
Registration of securities for employees
4:08pm
20-F
0w1v4avvy
1 Mar 22
Annual report (foreign)
4:44pm
6-K
tg4n9xu
9 Nov 21
Achilles Therapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights
10:38am
6-K
v7g8 cq9x
10 Aug 21
Achilles Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights
7:12am
6-K
3ikoyvdwww5
28 Jun 21
Current report (foreign)
4:04pm
6-K
a1fpdmmtz4fp
26 May 21
Current report (foreign)
4:59pm
6-K
6w2mw
11 May 21
Achilles Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Highlights
9:22am
6-K
ezowgn ghzfv
3 May 21
Achilles Therapeutics Appoints Julie O’Neill to Board of Directors
9:13am
SEC STAFF
c1kn2bczw5y 526v5
12 Apr 21
SEC staff action: Order
12:00am
S-8
obro3qzzy
6 Apr 21
Registration of securities for employees
4:21pm
424B4
b1sgo
31 Mar 21
Prospectus supplement with pricing info
5:09pm
EFFECT
10infeoi3a
31 Mar 21
Notice of effectiveness
12:15am
CERT
i82 f417w
30 Mar 21
Certification of approval for exchange listing
11:16am
8-A12B
erda5 j3w9m6nwrq
29 Mar 21
Registration of securities on exchange
4:51pm
F-1/A
omsm3
29 Mar 21
Registration statement (foreign) (amended)
4:02pm
CORRESP
liq9r
29 Mar 21
Correspondence with SEC
12:00am
CORRESP
up6xg2 ox9o2pa792
26 Mar 21
Correspondence with SEC
12:00am